IL10 and neoplasm: As shown in Fig. 7j and k, RD@MBs significantly reduced the secretion of IL-10 and increased IL-12, indicating that the combined treatment of R837 and DTX effectively induced the polarization of macrophages in the tumor microenvironment and evidently activated the antitumor inflammatory immune response.